|
Laparoscopic Sleeve Gastrectomy
 |
- First
performed as part of Duodenal Switch procedure 1988 (Marceau/Hess)
- First
performed in laparoscopic isolated form 1999 (Gagner)
- 35
published reports in the surgical literature describing clinical
outcomes in 2410 patients
- Risk
appears to be low even in high risk patients
- Overall
mortality rate: 0.19%
- No
consensus of optimal dilator size
- No
study provides data beyond 5 years postoperatively
- BMI
treatment range 35-69
|
|
|
Advantages |
Disadvantages |
- Gastric
restriction without loss of function
- Pylorus
preservation without dumping
- Short
hospital stay
- First
stage for super obese patients
- Useful
for patients with anemia or Crohn's disease
- No
foreign body or adjustment necessary
- No
problems with malabsorbtion
- Reduced
levels of plasma grehlin to induce satiety
|
- Stapling
complications
- Irreversibility
- Lack
of insurance coverage
- No
long term (greater than 5 year published
data)
- Durability
of weight loss/ Need for second stage surgery
|
|
